197 related articles for article (PubMed ID: 18212517)
1. Estrogen and progesterone modulate [35S]GTPgammaS binding to nociceptin receptors.
Quesada A; Micevych P
Neuroendocrinology; 2008; 88(1):35-42. PubMed ID: 18212517
[TBL] [Abstract][Full Text] [Related]
2. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF
Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H
Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754
[TBL] [Abstract][Full Text] [Related]
4. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
Sinchak K; Romeo HE; Micevych PE
J Comp Neurol; 2006 May; 496(2):252-68. PubMed ID: 16538678
[TBL] [Abstract][Full Text] [Related]
5. Distribution of nociceptin and Ro64-6198 activated [35S]-GTPgammaS binding in the rat brain.
Gehlert DR; Gackenheimer SL; Shaw JL
Neuropeptides; 2006 Apr; 40(2):95-105. PubMed ID: 16403422
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
[TBL] [Abstract][Full Text] [Related]
7. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.
Neal CR; Owens CE; Taylor LP; Hoversten MT; Akil H; Watson SJ
J Chem Neuroanat; 2003 Jul; 25(4):233-47. PubMed ID: 12842269
[TBL] [Abstract][Full Text] [Related]
8. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
Sim LJ; Childers SR
J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
[TBL] [Abstract][Full Text] [Related]
9. Identification of opioid receptor-like (ORL1) peptide-stimulated [35S]GTP gamma S binding in rat brain.
Sim LJ; Xiao R; Childers SR
Neuroreport; 1996 Feb; 7(3):729-33. PubMed ID: 8733732
[TBL] [Abstract][Full Text] [Related]
10. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
Hawkinson JE; Acosta-Burruel M; Espitia SA
Eur J Pharmacol; 2000 Feb; 389(2-3):107-14. PubMed ID: 10688973
[TBL] [Abstract][Full Text] [Related]
11. Opioid receptor-like 1 (NOP) receptors in the rat dorsal raphe nucleus: evidence for localization on serotoninergic neurons and functional adaptation after 5,7-dihydroxytryptamine lesion.
Le MaƮtre E; Vilpoux C; Costentin J; Leroux-Nicollet I
J Neurosci Res; 2005 Aug; 81(4):488-96. PubMed ID: 15948180
[TBL] [Abstract][Full Text] [Related]
12. Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5'-O-(gamma-thio)-triphosphate binding in rat brain membranes.
Albrecht E; Samovilova NN; Oswald S; Baeger I; Berger H
J Pharmacol Exp Ther; 1998 Aug; 286(2):896-902. PubMed ID: 9694948
[TBL] [Abstract][Full Text] [Related]
13. Estrogen modulation of mu-opioid receptor-stimulated [35S]-GTP-gamma-S binding in female rat brain visualized by in vitro autoradiography.
Acosta-Martinez M; Etgen AM
Neuroendocrinology; 2002 Oct; 76(4):235-42. PubMed ID: 12411740
[TBL] [Abstract][Full Text] [Related]
14. Visualizing activation of opioid circuits by internalization of G protein-coupled receptors.
Sinchak K; Micevych P
Mol Neurobiol; 2003 Apr; 27(2):197-222. PubMed ID: 12777688
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Azuma T; Ichikawa D; Nambu H; Iguchi T; Iwasawa Y; Ohta H
Eur J Pharmacol; 2000 Aug; 402(1-2):45-53. PubMed ID: 10940356
[TBL] [Abstract][Full Text] [Related]
16. N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.
Judd AK; Kaushanskaya A; Tuttle DJ; Sanchez A; Khroyan T; Polgar W; Toll L
J Pept Res; 2003 Nov; 62(5):191-8. PubMed ID: 14531842
[TBL] [Abstract][Full Text] [Related]
17. mu-Opioid agonist-stimulated [35S]GTPgammaS binding in guinea pig hypothalamus: effects of estrogen.
Cunningham MJ; Fang Y; Selley DE; Kelly MJ
Brain Res; 1998 Apr; 791(1-2):341-6. PubMed ID: 9593984
[TBL] [Abstract][Full Text] [Related]
18. Binding of GTPgamma[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor.
McDonald J; Lambert DG
Br J Pharmacol; 2010 Mar; 159(6):1286-93. PubMed ID: 20148892
[TBL] [Abstract][Full Text] [Related]
19. Dual coupling of opioid receptor-like (ORL1) receptors to adenylyl cyclase in the different layers of the rat main olfactory bulb.
Onali P; Ingianni A; Olianas MC
J Neurochem; 2001 Jun; 77(6):1520-30. PubMed ID: 11413235
[TBL] [Abstract][Full Text] [Related]
20. Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: activation of inhibitory G protein and homologous desensitization.
Cheng ZJ; Fan GH; Zhao J; Zhang Z; Wu YL; Jiang LZ; Zhu Y; Pei G; Ma L
Neuroreport; 1997 May; 8(8):1913-8. PubMed ID: 9223076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]